Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.

Fu F, Li W, Lu L, Fung JJ, Thomson AW, Qian S. Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors. Transplant Proc. 1999 Feb-Mar; 31(1-2):453.

View in: PubMed

collapse authors with profiles